The tear and plasma pharmacokinetics study of TS-1 monotherapy for gastric cancer patients.
Phase of Trial: Phase II
Latest Information Update: 29 Jan 2018
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Gastric cancer
- Focus Pharmacokinetics
- 25 Jan 2018 Status changed from active, no longer recruiting to completed.
- 20 Jan 2018 Results assessing association between tear and plasma concentrations of Tegafur, 5-Fluorouracil, and 5-chloro-2,4-dihydroxypyridine presented at the 2018 Gastrointestinal Cancers Symposium
- 27 Mar 2017 Status changed from recruiting to active, no longer recruiting.